http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1317125-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d037bc74e34c7d73dd883f208aef0518 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-22 |
| filingDate | 1971-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1973-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1317125-A |
| titleOfInvention | Piperazine compositions and method of treatment |
| abstract | 1317125 Therapeutic piperazine compositions GROPPO LEPETIT SpA 28 May 1971 [1 June 1970 3 Feb 1971] 17987/71 Heading A5B [Also in Division C2] Pharmaceutical compositions of a piperazine compound of the formula I wherein X is H 2 , benzylidene or a group (H, acyl) where acyl is a C 2-6 aliphatic carbonyl group; R is C 2-6 alkyl, phenyl-C 1-6 -alkyl or C 2-6 aliphatic carbonyl or when X is other than H 2 , also hydrogen or methyl; R<SP>1</SP>, R<SP>2</SP>, R<SP>3</SP> and R<SP>4</SP> each are hydrogen or C 1-6 alkyl, with the proviso that when R is benzyl at least one of the radicals R<SP>1</SP>, R<SP>2</SP>, R<SP>3</SP> and R<SP>4</SP> is not hydrogen, or each of the pairs R<SP>1</SP> and R<SP>2</SP> or R<SP>3</SP> and R<SP>4</SP> are a C 2-6 alkylidene radical bridging the piperazine ring or a pharmaceutically acceptable acid addition salt thereof with the usual excipients are useful for the treatment of virus diseases. |
| priorityDate | 1970-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.